FERMENTA BIOTECH Financial Statement Analysis
|
||
The Revenues of FERMENTA BIOTECH have decreased by -12.19% YoY .
The Earnings Per Share (EPS) of FERMENTA BIOTECH has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
FERMENTA BIOTECH Last 5 Annual Financial Results
[BOM: 506414]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹350 Cr | ₹399 Cr | ₹377 Cr | ₹293 Cr | ₹405 Cr |
Expenses | ₹331 Cr | ₹336 Cr | ₹295 Cr | ₹229 Cr | ₹269 Cr |
Operating Profit (Excl OI) | ₹19 Cr | ₹62 Cr | ₹83 Cr | ₹64 Cr | ₹135 Cr |
Other Income | ₹7.69 Cr | ₹8.25 Cr | ₹8.37 Cr | ₹14 Cr | ₹27 Cr |
Interest | ₹21 Cr | ₹18 Cr | ₹19 Cr | ₹20 Cr | ₹21 Cr |
Depreciation | ₹28 Cr | ₹26 Cr | ₹20 Cr | ₹15 Cr | ₹12 Cr |
Profit Before Tax | ₹-52 Cr | ₹27 Cr | ₹52 Cr | ₹43 Cr | ₹129 Cr |
Profit After Tax | ₹-54 Cr | ₹15 Cr | ₹43 Cr | ₹60 Cr | ₹118 Cr |
Consolidated Net Profit | ₹-51 Cr | ₹15 Cr | ₹46 Cr | ₹60 Cr | ₹117 Cr |
Earnings Per Share (Rs) | ₹-17.85 | ₹5.35 | ₹15.77 | ₹20.63 | ₹128.05 |
PAT Margin (%) | -15.30 | 3.78 | 11.27 | 20.32 | 29.14 |
ROE(%) | -16.26 | 4.27 | 13.05 | 21.92 | 64.77 |
ROCE(%) | -5.35 | 7.50 | 12.62 | 12.98 | 40.16 |
Total Debt/Equity(x) | 0.72 | 0.66 | 0.66 | 0.73 | 0.87 |
Key Financials |
||
Market Cap | : | ₹ 506.7 Cr |
Revenue (TTM) | : | ₹ 343.5 Cr |
Net Profit(TTM) | : | ₹ -21.8 Cr |
EPS (TTM) | : | ₹ -7.4 |
P/E (TTM) | : | - |
Industry Peers & Returns | 1W | 1M | 1Y |
FERMENTA BIOTECH | -2.2% | -23.9% | 14.6% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
FERMENTA BIOTECH Revenues
[BOM: 506414]
Y-o-Y | -12.19 % |
5 Yr CAGR | -3.57 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹350 Cr | -12.19 | |
Mar2022 | ₹399 Cr | 5.63 | |
Mar2021 | ₹377 Cr | 28.79 | |
Mar2020 | ₹293 Cr | -27.61 | |
Mar2019 | ₹405 Cr | - |
FERMENTA BIOTECH Operating Profit
[BOM: 506414]
Y-o-Y | -70.23 % |
5 Yr CAGR | -39.17 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹19 Cr | -70.23 | |
Mar2022 | ₹62 Cr | -24.64 | |
Mar2021 | ₹83 Cr | 28.41 | |
Mar2020 | ₹64 Cr | -52.48 | |
Mar2019 | ₹135 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -66.13 % |
5 Yr CAGR | -36.93 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 5.29% | -66.13 | |
Mar2022 | 15.62% | -28.64 | |
Mar2021 | 21.89% | -0.27 | |
Mar2020 | 21.95% | -34.36 | |
Mar2019 | 33.44% | - |
FERMENTA BIOTECH Profit After Tax
[BOM: 506414]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹-51 Cr | Negative | |
Mar2022 | ₹15 Cr | -66.06 | |
Mar2021 | ₹46 Cr | -23.55 | |
Mar2020 | ₹60 Cr | -49.32 | |
Mar2019 | ₹117 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | -15.3 % | Negative | |
Mar2022 | 3.78 % | -66.46 | |
Mar2021 | 11.27 % | -44.54 | |
Mar2020 | 20.32 % | -30.27 | |
Mar2019 | 29.14 % | - |
FERMENTA BIOTECH Earnings Per Share (EPS)
[BOM: 506414]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹-18 | Negative | |
Mar2022 | ₹5.35 | -66.07 | |
Mar2021 | ₹16 | -23.56 | |
Mar2020 | ₹21 | -83.89 | |
Mar2019 | ₹128 | - |
FERMENTA BIOTECH Return on Capital Employed (ROCE)
[BOM: 506414]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | -5.35% | Negative | |
Mar2022 | 7.5% | -40.57 | |
Mar2021 | 12.62% | -2.77 | |
Mar2020 | 12.98% | -67.68 | |
Mar2019 | 40.16% | - |
FERMENTA BIOTECH Share Price vs Sensex
Current Share Price | : | ₹172.4 |
Current MarketCap | : | ₹ 506.7 Cr |
Updated EOD on | : | Apr 22,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FERMENTA BIOTECH | -2.2% |
-23.9% |
14.6% |
SENSEX | -0.8% |
1.4% |
22.9% |
FERMENTA BIOTECH related INDICES
You may also like the below Video Courses
FAQ about FERMENTA BIOTECH Financials
How the annual revenues of FERMENTA BIOTECH have changed ?
The Revenues of FERMENTA BIOTECH have decreased by -12.19% YoY .
How the Earnings per Share (EPS) of FERMENTA BIOTECH have changed?
The Earnings Per Share (EPS) of FERMENTA BIOTECH has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs